Skip to Content


In the US, Imatinib (imatinib systemic) is a member of the drug class BCR-ABL tyrosine kinase inhibitors and is used to treat Acute Lymphoblastic Leukemia, Chronic Eosinophilic Leukemia, Chronic Myelogenous Leukemia, Dermatofibrosarcoma Protuberans, Gastrointestinal Stromal Tumor, Hypereosinophilic Syndrome, Myelodysplastic Diseases, Myeloproliferative Disorders and Systemic Mastocytosis.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Antineoplastic agent: Tyrosine kinase inhibitor

Chemical Names

alpha-(4-metyl-1-piperazinyl)-3'-[[4-(3-pyridyl)-2-pyrimidinyl]amino]-p-tolu-p-toluidide- (WHO)

Benzamide, 4-((4-metyl)-1-piperazinyl)metyl)-N-(4-metyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)phenyl)-

Foreign Names

  • Imatinibum (Latin)
  • Imatinib (German)
  • Imatinib (French)
  • Imatinib (Spanish)

Generic Names

  • Imatinib (OS: BAN)
  • CGP 57148 (IS)
  • Imatinib Mesilate (OS: BAN, JAN)
  • Imatinib Mesylate (OS: USAN)
  • CGP 57148B (IS: Novartis)
  • chronic myeloid leukemia (IS: CML)
  • CML (IS)
  • Imatinib Mesylate (IS)
  • STI 571 (IS: Novartis)
  • Imatinib mesilate (PH: Ph. Eur. 8)
  • Imatinibi mesilas (PH: Ph. Eur. 8)
  • Imatinibmesilat (PH: Ph. Eur. 8)

Brand Names


BANBritish Approved Name
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.